Search results for: 'sirtuin modulator'
- BA6659 BasmisanilSummary: Basmisanil (RG1662) is a highly selective alpha-subunit-containing GABAA receptor (GABAAα5)-negative modulator with oral activity.
- BA6755 GNE-9278Summary: GNE-9278 is a highly selective orthosteric modulator that acts on the GluN1 transmembrane structural domain (TMD).
- BA8589 BPN-15606Summary: BPN-15606 is a potent oral activity modulator (GSM) that attenuates SHSY5Y neuroblastoma cell production.
- BA8590 PF-06648671Summary: PF-06648671 is a novel, blood-brain barrier permeable, orally active gamma secretase modulator (GSM).
- BA1841 BA-53038BSummary: BA-53038B is a core protein alteration modulator (CpAM) that binds to the HAP pocket and regulates coat assembly.
- BA5597 VU6001966Summary: VU6001966 is a potent negative-conversion modulator that crosses the blood-brain barrier, with mGlu2 and mGlu3's of 78nM and >30μM, respectively.
- BA6619 BamocaftorSummary: Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance modulator corrector designed to restore protein function.
- BA6813 BNC210Summary: BNC210 (H-Ile-Trp-OH) is an orally effective, negative alteration modulator (NAM) without significant side effects.
- BA6874 RimtuzalcapSummary: Rimtuzalcap (CAD-1883) is a first-of-its-kind, selective small conductance calcium-activated potassium channel (channel) orthosteric modulator.
- BA5507 VU0467485Summary: VU0467485 (AZ13713945) is a potent, selective, orally bioavailable muscarinic acetylcholine receptor 4 orthosteric modulator (PAM).